Published date: 7 May 2019

This notice was replaced on 26 September 2019

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 26 September 2019)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Isle of Man, Channel Islands

Value of contract

£112,862,543

Procurement reference

tender_205341/763943

Published date

7 May 2019

Closing date

7 June 2019

Contract start date

1 October 2019

Contract end date

28 February 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Pharmaceuticals Transition 2019_1
Offer reference number: CM/PHG/17/5547
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 34 months
Potential periods of call-offs under the framework agreement:
LSNE: 01/10/2019 to 30/04/2020 (7 months)
CESW: 01/10/2019 to 30/09/2020 (12 months)
NWLN: 01/10/2019 to 28/02/2021 (17 months)

More information

Attachments

Links

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

gemma.tomlinson1@nhs.net